Brokerages Set Doximity, Inc. (NASDAQ:DOCS) Price Target at $53.12

Doximity, Inc. (NASDAQ:DOCSGet Free Report) has earned a consensus rating of “Hold” from the twenty brokerages that are covering the stock, MarketBeat reports. Thirteen research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $53.12.

Several analysts recently commented on DOCS shares. Barclays increased their price objective on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Raymond James reiterated an “outperform” rating and set a $65.00 price target (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. KeyCorp reduced their price target on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Bank of America upped their price objective on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Finally, Mizuho started coverage on Doximity in a report on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 target price for the company.

View Our Latest Stock Analysis on DOCS

Institutional Trading of Doximity

Several hedge funds have recently bought and sold shares of the stock. UMB Bank n.a. boosted its holdings in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after acquiring an additional 603 shares in the last quarter. Quarry LP boosted its stake in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares during the period. Morse Asset Management Inc purchased a new stake in shares of Doximity during the third quarter worth about $46,000. Finally, GAMMA Investing LLC raised its stake in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after purchasing an additional 412 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Down 0.6 %

Shares of DOCS stock opened at $55.69 on Tuesday. The company’s fifty day moving average price is $53.66 and its 200-day moving average price is $43.22. The stock has a market cap of $10.40 billion, a PE ratio of 64.02, a price-to-earnings-growth ratio of 4.39 and a beta of 1.38. Doximity has a 12 month low of $22.96 and a 12 month high of $61.75.

Doximity (NASDAQ:DOCSGet Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). Doximity had a return on equity of 19.79% and a net margin of 33.69%. The business had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. During the same quarter last year, the company posted $0.18 EPS. On average, sell-side analysts forecast that Doximity will post 0.88 earnings per share for the current fiscal year.

About Doximity

(Get Free Report

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.